myristoyl octapeptide-31은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

myristoyl octapeptide-31은 임신 중 안전한가요?

No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment flagging reproductive hazard. Peer‑reviewed literature and public databases (PubChem, CosIng) contain no reproductive toxicity or teratogenicity data for myristoyl octapeptide‑31. As an acylated cosmetic peptide with increased lipophilicity vs the parent peptide, topical absorption is plausible but expected to be low for typical cosmetic use (hence exposure = 1). Sources consulted: ECHA Annex VI (no harmonised CLP), CosIng, PubChem, PubMed (no reproductive studies found), CIR (no assessment).

myristoyl octapeptide-31은 모유 수유 중 안전한가요?

No data indicating damage to lactation or transfer into breastmilk; no harmonised classification or regulatory safety warnings. By analogy to other topical peptides and given modest dermal absorption potential, low but measurable exposure is assumed during topical use. Same data sources as for pregnancy show no reproductive/lactation concerns.

myristoyl octapeptide-31은 아기 피부에 안전한가요?

No infant‑specific toxicology or dermal absorption studies identified. Because infant skin (0–3 yr) has higher surface‑area‑to‑bodyweight and a less mature barrier, dermal exposure was conservatively increased by one exposure level versus adults (adult e=1 → baby e=2). No evidence suggests increased inherent reproductive or mechanistic hazard to infants.

VeriMom은 myristoyl octapeptide-31을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 myristoyl octapeptide-31을 93/100 (알려진 위험 없음)로 평가합니다.

임신 중 myristoyl octapeptide-31 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.